Clinical trial · Observational
Young Survivors at Kantonsspital Aarau, Switzerland
Young Survivors at Kantonsspital Aarau, Switzerland - A Standardized Assessment of Long-Term and Late-Onset Health Events in Survivors of Childhood and Adolescent Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Young Survivors at Kantonsspital Aarau project assesses the prevalence and severity of late effects in survivors of childhood and adolescent cancer according to the modified CTCAE criteria prospectively. The clinical data are generated during regular follow-up care visits, the collection starts directly after completion of treatment and is longitudinally.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
| Late Effects | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Personal history | Other | — | UNRESOLVED |
| Physical examination, diagnostic tests, laboratory tests | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Group A (largest part of the cohort)
- description
- Children, adolescents, and adults who are still in follow-up care (data are collected retrospectively until 2016 at the most)
- interventionNames
- Other: Physical examination, diagnostic tests, laboratory tests
- Other: Personal history
- label
- Group B (very small part of the cohort)
- description
- Children, adolescents, and adults who left follow-up care (data are collected retrospectively until 2016 at the most)
- interventionNames
- Other: Physical examination, diagnostic tests, laboratory tests
- Other: Personal history
Primary outcomes (1)
- measure
- Test results to assess organ-specific late effects (example of cardiac health)
- timeFrame
- at recruitment or 2016 onwards, whichever comes first
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Group A: Children and adolescents who: * have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau, * have been diagnosed at age 0-18 years, * are still in regular follow-up care at the Kantonsspital Aarau, * have finished cancer treatment and entered follow-up care, and * signed informed consent Group B: Adolescents and adults who: * fulfill the same inclusion criteria as Group A * are not in regular follow-up care anymore Exclusion Criteria: Childhood Cancer Survivors who: * are in a palliative situation or * have not given consent for further use of medical data
References
Publications (1)
- DERIVEDOtth M, Drozdov D, Hugli C, Scheinemann K. Young Survivors at KSA: registry for standardised assessment of long-term and late-onset health events in survivors of childhood and adolescent cancer-a study protocol. BMJ Open. 2021 Dec 3;11(12):e053749. doi: 10.1136/bmjopen-2021-053749. PMID 34862296